首页> 外文期刊>Pharmaceutics >Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence
【24h】

Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence

机译:局部半固体中微结构参数的批间变异性及其对等效性证明的影响

获取原文
获取外文期刊封面目录资料

摘要

Demonstration of similar microstructure is essential for demonstrating the equivalence of generic topical products since the microstructure of semisolids may affect the drug release. The objective of this study was to compare the microstructure-defining physical parameters of different batches of a reference ointment containing calcipotriol and betamethasone (Daivobet 50 μg/0.5 mg/g) in order to define the acceptance range that allows concluding equivalence between these batches. Being batches of the same reference product, they are expected to be clinically equivalent and possess similar microstructure. The 90% confidence intervals for the test/reference ratio of these physical parameters were calculated with parametric and non-parametric approaches. Both methods conclude that equivalent microstructure between batches cannot be demonstrated with a reasonable sample size when the acceptance range was set at ±10%, since several physical parameters exhibit inter-batch variability 10%. An acceptance range of ±10% is therefore too strict to conclude equivalence in the microstructure of semisolid dosage forms, given the inter-batch variability observed between batches of the reference product. A wider fixed acceptance range or an acceptance range widened based on the inter-batch variability of the reference product would be advisable.
机译:由于半固体的微观结构可能会影响药物的释放,因此证明相似的微观结构对于证明一般性局部用产品的等效性至关重要。这项研究的目的是比较含有卡泊三醇和倍他米松(Daivobet 50μg/ 0.5 mg / g)的参考软膏不同批次的定义微观结构的物理参数,以定义可接受的范围,从而确定这些批次之间的等效性。作为同一参考产品的批次,它们有望在临床上等效并且具有相似的微观结构。这些物理参数的测试/参考比率的90%置信区间是使用参数方法和非参数方法计算的。两种方法均得出结论,当可接受范围设置为±10%时,无法用合理的样本量证明批次之间的等效微观结构,因为一些物理参数显示批次间变异性> 10%。因此,鉴于参考产品批次之间观察到的批间差异,±10%的可接受范围太严格,无法得出半固体剂型微观结构的等效性。建议根据参考产品的批间差异,采用更宽的固定接受范围或扩大的接受范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号